JPRN-UMIN000004918已完成未知
Silodosin 4mg versus tamsulosin 0.2mg once daily; randomized crossover study - Silodosin 4mg versus tamsulosin 0.2mg once daily; randomized crossover study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Patients who took alfa 1 blocker within 28 days; patients who were taking phosphodiesterase 5 inhibitor, 5 alfa reductase inhibitor and antiandrogen; patients with severe renal disfunction (eGFR<30ml/min/1.73m2); or patients who were judged to be inappropirate by physicians.
研究者
相似试验
尚未招募
3 期
Comparison between silodosin and tamsulosin for medical expulsive therapy of lower ureteric stonesCTRI/2020/11/029244Atif Abdullah C
尚未招募
3 期
COMPARISON OF TAMSULOSIN AND SILODOSIN IN TREATMENT OF LOWER URETERIC STONESCTRI/2019/07/019961ARUNCHAND R
招募中
3 期
Silodosin alone versus Tamsulosin with Tadalafil as medical expulsive therapy for distal ureteric stones: A Prospective Randomized Trial.CTRI/2023/06/054090Sun Pharma
尚未招募
不适用
Comparison of Silodosin & tamsulosin in management of prostate enlargementCTRI/2019/11/021996niversity College of Medical Sciences University of Delhi
招募中
2 期
Effect of Tamsulosin on ProstateBenign prostatic hyperplasia.Hyperplasia of prostateIRCT20160514027893N3Bojnourd University of Medical Sciences80